Pyridinolcarbamate, bradykinin antagonist, in patients suffering from arteriosclerosis obliterans and thromboangiitis obliterans (Buerger's disease); a preliminary report on the treatment of human atherosclerosis.
D000328:Adult; D000963:Antimetabolites / Q000627:therapeutic use*; D001162:Arteriosclerosis Obliterans / Q000188:drug therapy*; D001777:Blood Coagulation / Q000187:drug effects; D001920:Bradykinin; D002219:Carbamates / Q000627:therapeutic use*; D002784:Cholesterol; D006801:Humans; D008297:Male; D008875:Middle Aged; D013919:Thromboangiitis Obliterans / Q000188:drug therapy*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000963:Antimetabolites; D002219:Carbamates; D014665:Vasodilator Agents; D002784:Cholesterol; D001920:Bradykinin